Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly’s tirzepatide achieves superior A1C reductions versus insulin glargine

pharmatimesMay 25, 2021

Tag: Lilly , tirzepatide , A1C

PharmaSources Customer Service